B
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Brenda M. Gannon's research focuses on the abuse-related effects of drugs and drug mixtures, particularly synthetic cathinones and novel arylcyclohexylamines. Her work investigates the interactions of these substances with monoamine transporters, such as the norepinephrine transporter, and their impact on behavior in rodent models. Gannon has published on the development of cannabinoids as therapeutic agents and the role of the endocannabinoid system in alcohol dependence. Her studies also examine phencyclidine-like abuse liability and psychosis-like neurocognitive effects of novel drugs. Gannon is affiliated with the University of Arkansas for Medical Sciences and has a notable number of shared publications with collaborators including William E. Fantegrossi and Lauren R. Fitzgerald. Her scholarship includes 50 publications and a h-index of 16, with 906 total citations.
Metrics
- h-index: 16
- Publications: 51
- Citations: 911
Selected Publications
-
Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations (2025)
-
Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption (2025)
-
A “Furious” Effort to Develop Novel 3,4-Methylenedioxymethamphetamine-Like Therapeutics (2024)
-
Respiratory Depressant Effects of Fentanyl in Combination With Synthetic Cannabinoid Receptor Agonists: A Potential Mechanism for “Narcan-Resistant” Overdose (2024)
-
The Development of Cannabinoids as Therapeutic Agents in the United States (2024)
-
Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917] (2024)
-
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents (2024)
-
Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones (2023)
-
Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety (2023)
Collaboration Network
Top Collaborators
William E. Fantegrossi
University of Arkansas for Medical Sciences
9 shared publications
In database
- Effects of Laboratory Housing Conditions on Core Temperature and Locomotor Activity in Mice
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
Showing 5 of 9 shared publications
Lauren R. Fitzgerald
University of Arkansas for Medical Sciences
4 shared publications
In database
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Kenner C. Rice
National Institute on Alcohol Abuse and Alcoholism (US)
3 shared publications
- MDPV “high-responder” rats also self-administer more oxycodone than their “low-responder” counterparts under a fixed ratio schedule of reinforcement
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Kevin S. Murnane
Mercer University Health Sciences Center (US)
3 shared publications
- α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter
- MDPV “high-responder” rats also self-administer more oxycodone than their “low-responder” counterparts under a fixed ratio schedule of reinforcement
- The Endocannabinoid System and Alcohol Dependence: Will CannabinoidReceptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?
Bruce E. Blough
RTI International (US)
2 shared publications
- α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter
- Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones
Gregory T. Collins
The University of Texas Health Science Center at San Antonio (US)
2 shared publications
- Application of dose‐addition analyses to characterize the abuse‐related effects of drug mixtures
- Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations
Christopher O. Godwin
University of Arkansas for Medical Sciences
2 shared publications
In database
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Heidi D. Hughes-Meredith
University of Arkansas for Medical Sciences
2 shared publications
In database
- Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety
- Erratum to “Effects of ambient temperature on locomotor activity and place conditioning elicited by abused psychostimulants in mice: Role of 3,4-methylenedioxy moiety” [Drug Alcohol Depend. 250 (2023) 110917]
Hannah E. Shaw
University of Arkansas for Medical Sciences
2 shared publications
In database
- Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents
- Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption
Ziva D. Cooper
Neurobehavioral Systems (US)
2 shared publications
- The Development of Cannabinoids as Therapeutic Agents in the United States
- Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations
Aboagyewaah Oppong‐Damoah
Mercer University Health Sciences Center (US)
1 shared publication
- The Endocannabinoid System and Alcohol Dependence: Will CannabinoidReceptor 2 Agonism be More Fruitful than Cannabinoid Receptor 1 Antagonism?
Julian Maier
Medical University of Vienna (AT)
1 shared publication
- α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter
Laurin Rauter
Medical University of Vienna (AT)
1 shared publication
- α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter
Deborah Rudin
Medical University of Vienna (AT)
1 shared publication
- α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter
Marco Niello
Medical University of Vienna (AT)
1 shared publication
- α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter
Similar Researchers
Based on overlapping research topics
Dylan R. Patel
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
William Fantegrossi
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Catheryn D. Wilson
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Melinda G. Gunnell
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
A. George Wilson
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Christopher O. Godwin
University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research
Pharmacological Effects and Toxicity Studies
Behavioral and Psychological Studies